Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice

The therapeutic activity of cefozopran, a new semisynthetic parenteral cephalosporin, was compared with those of ceftazidime, ampicillin, imipenem/cilastatin and ofloxacin against an ascending mixed urinary tract infection induced in mice with Enterococcus faecalis TN2005 and Pseudomonas aeruginosa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 1997-03, Vol.39 (3), p.423-425
Hauptverfasser: TSUCHIMORI, N, YAMAZAKI, T, OKONOGI, K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 425
container_issue 3
container_start_page 423
container_title Journal of antimicrobial chemotherapy
container_volume 39
creator TSUCHIMORI, N
YAMAZAKI, T
OKONOGI, K
description The therapeutic activity of cefozopran, a new semisynthetic parenteral cephalosporin, was compared with those of ceftazidime, ampicillin, imipenem/cilastatin and ofloxacin against an ascending mixed urinary tract infection induced in mice with Enterococcus faecalis TN2005 and Pseudomonas aeruginosa P9. Cefozopran significantly reduced viable cell counts of both organisms in the kidneys. Ceftazidime, imipenem/cilastatin and ofloxacin were active against only P. aeruginosa, and ampicillin was active against only E. faecalis.
doi_str_mv 10.1093/jac/39.3.423
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78937535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78937535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-ec63d27ff74253111d4babd840573c45779bfa8d1bc0ae9eef6207a3c0315cbc3</originalsourceid><addsrcrecordid>eNqFkc1u1TAQRi0EKpfCji2SF4gVubXjOI6XqCo_UiVYlHU0mYxbVzd2sB218Bg8Ma561S2r0WjOfIvvMPZWir0UVp3dAp4pu1f7rlXP2E52vWhaYeVzthNK6MZ0Wr1kr3K-FUL0uh9O2IkVtpdW79jfqxtKsNJWPHJyjrBkHh1HcvFPXBMEDtfgQy6c7ldKfqFQ4MAXf08z35IPkH7zkgAL9-Hh3cfA73y54RehUIoYEbfMHRDCwWcOYeY_Mm1zXGKAulParn2IGep_jUV6zV44OGR6c5yn7Ofni6vzr83l9y_fzj9dNqiGrjSEvZpb45zpWq2klHM3wTQPndBGYaeNsZODYZYTCiBL5PpWGFAolNQ4oTplHx5z1xR_bZTLuPiMdDhAoLjl0QxWGa30f0GprR2G3lTw4yOIKeacyI1rLawWNEoxPrgaq6tR2VGN1VXF3x1zt2mh-Qk-yqn398c75FqeqzLQ5yesrZCxVv0DBQugpw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15998867</pqid></control><display><type>article</type><title>Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Free Full-Text Journals in Chemistry</source><creator>TSUCHIMORI, N ; YAMAZAKI, T ; OKONOGI, K</creator><creatorcontrib>TSUCHIMORI, N ; YAMAZAKI, T ; OKONOGI, K</creatorcontrib><description>The therapeutic activity of cefozopran, a new semisynthetic parenteral cephalosporin, was compared with those of ceftazidime, ampicillin, imipenem/cilastatin and ofloxacin against an ascending mixed urinary tract infection induced in mice with Enterococcus faecalis TN2005 and Pseudomonas aeruginosa P9. Cefozopran significantly reduced viable cell counts of both organisms in the kidneys. Ceftazidime, imipenem/cilastatin and ofloxacin were active against only P. aeruginosa, and ampicillin was active against only E. faecalis.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/39.3.423</identifier><identifier>PMID: 9096195</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Ampicillin - therapeutic use ; Animals ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cefozopran ; Ceftazidime - pharmacology ; Ceftazidime - therapeutic use ; Cephalosporins - therapeutic use ; Cilastatin - therapeutic use ; Enterococcus faecalis ; Female ; Gram-Positive Bacterial Infections - drug therapy ; Imipenem - pharmacology ; Imipenem - therapeutic use ; Medical sciences ; Mice ; Mice, Inbred CBA ; Ofloxacin - pharmacology ; Ofloxacin - therapeutic use ; Pharmacology. Drug treatments ; Pseudomonas aeruginosa ; Pseudomonas Infections - drug therapy ; Urinary Tract Infections - drug therapy</subject><ispartof>Journal of antimicrobial chemotherapy, 1997-03, Vol.39 (3), p.423-425</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-ec63d27ff74253111d4babd840573c45779bfa8d1bc0ae9eef6207a3c0315cbc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2619799$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9096195$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TSUCHIMORI, N</creatorcontrib><creatorcontrib>YAMAZAKI, T</creatorcontrib><creatorcontrib>OKONOGI, K</creatorcontrib><title>Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The therapeutic activity of cefozopran, a new semisynthetic parenteral cephalosporin, was compared with those of ceftazidime, ampicillin, imipenem/cilastatin and ofloxacin against an ascending mixed urinary tract infection induced in mice with Enterococcus faecalis TN2005 and Pseudomonas aeruginosa P9. Cefozopran significantly reduced viable cell counts of both organisms in the kidneys. Ceftazidime, imipenem/cilastatin and ofloxacin were active against only P. aeruginosa, and ampicillin was active against only E. faecalis.</description><subject>Ampicillin - therapeutic use</subject><subject>Animals</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cefozopran</subject><subject>Ceftazidime - pharmacology</subject><subject>Ceftazidime - therapeutic use</subject><subject>Cephalosporins - therapeutic use</subject><subject>Cilastatin - therapeutic use</subject><subject>Enterococcus faecalis</subject><subject>Female</subject><subject>Gram-Positive Bacterial Infections - drug therapy</subject><subject>Imipenem - pharmacology</subject><subject>Imipenem - therapeutic use</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred CBA</subject><subject>Ofloxacin - pharmacology</subject><subject>Ofloxacin - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Urinary Tract Infections - drug therapy</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1TAQRi0EKpfCji2SF4gVubXjOI6XqCo_UiVYlHU0mYxbVzd2sB218Bg8Ma561S2r0WjOfIvvMPZWir0UVp3dAp4pu1f7rlXP2E52vWhaYeVzthNK6MZ0Wr1kr3K-FUL0uh9O2IkVtpdW79jfqxtKsNJWPHJyjrBkHh1HcvFPXBMEDtfgQy6c7ldKfqFQ4MAXf08z35IPkH7zkgAL9-Hh3cfA73y54RehUIoYEbfMHRDCwWcOYeY_Mm1zXGKAulParn2IGep_jUV6zV44OGR6c5yn7Ofni6vzr83l9y_fzj9dNqiGrjSEvZpb45zpWq2klHM3wTQPndBGYaeNsZODYZYTCiBL5PpWGFAolNQ4oTplHx5z1xR_bZTLuPiMdDhAoLjl0QxWGa30f0GprR2G3lTw4yOIKeacyI1rLawWNEoxPrgaq6tR2VGN1VXF3x1zt2mh-Qk-yqn398c75FqeqzLQ5yesrZCxVv0DBQugpw</recordid><startdate>19970301</startdate><enddate>19970301</enddate><creator>TSUCHIMORI, N</creator><creator>YAMAZAKI, T</creator><creator>OKONOGI, K</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19970301</creationdate><title>Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice</title><author>TSUCHIMORI, N ; YAMAZAKI, T ; OKONOGI, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-ec63d27ff74253111d4babd840573c45779bfa8d1bc0ae9eef6207a3c0315cbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Ampicillin - therapeutic use</topic><topic>Animals</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cefozopran</topic><topic>Ceftazidime - pharmacology</topic><topic>Ceftazidime - therapeutic use</topic><topic>Cephalosporins - therapeutic use</topic><topic>Cilastatin - therapeutic use</topic><topic>Enterococcus faecalis</topic><topic>Female</topic><topic>Gram-Positive Bacterial Infections - drug therapy</topic><topic>Imipenem - pharmacology</topic><topic>Imipenem - therapeutic use</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred CBA</topic><topic>Ofloxacin - pharmacology</topic><topic>Ofloxacin - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Urinary Tract Infections - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TSUCHIMORI, N</creatorcontrib><creatorcontrib>YAMAZAKI, T</creatorcontrib><creatorcontrib>OKONOGI, K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TSUCHIMORI, N</au><au>YAMAZAKI, T</au><au>OKONOGI, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1997-03-01</date><risdate>1997</risdate><volume>39</volume><issue>3</issue><spage>423</spage><epage>425</epage><pages>423-425</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>The therapeutic activity of cefozopran, a new semisynthetic parenteral cephalosporin, was compared with those of ceftazidime, ampicillin, imipenem/cilastatin and ofloxacin against an ascending mixed urinary tract infection induced in mice with Enterococcus faecalis TN2005 and Pseudomonas aeruginosa P9. Cefozopran significantly reduced viable cell counts of both organisms in the kidneys. Ceftazidime, imipenem/cilastatin and ofloxacin were active against only P. aeruginosa, and ampicillin was active against only E. faecalis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>9096195</pmid><doi>10.1093/jac/39.3.423</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1997-03, Vol.39 (3), p.423-425
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_78937535
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Free Full-Text Journals in Chemistry
subjects Ampicillin - therapeutic use
Animals
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Cefozopran
Ceftazidime - pharmacology
Ceftazidime - therapeutic use
Cephalosporins - therapeutic use
Cilastatin - therapeutic use
Enterococcus faecalis
Female
Gram-Positive Bacterial Infections - drug therapy
Imipenem - pharmacology
Imipenem - therapeutic use
Medical sciences
Mice
Mice, Inbred CBA
Ofloxacin - pharmacology
Ofloxacin - therapeutic use
Pharmacology. Drug treatments
Pseudomonas aeruginosa
Pseudomonas Infections - drug therapy
Urinary Tract Infections - drug therapy
title Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T09%3A37%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20effects%20of%20cefozopran%20against%20experimental%20mixed%20urinary%20tract%20infection%20with%20Enterococcus%20faecalis%20and%20Pseudomonas%20aeruginosa%20in%20mice&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=TSUCHIMORI,%20N&rft.date=1997-03-01&rft.volume=39&rft.issue=3&rft.spage=423&rft.epage=425&rft.pages=423-425&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/39.3.423&rft_dat=%3Cproquest_cross%3E78937535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15998867&rft_id=info:pmid/9096195&rfr_iscdi=true